Search Results 2181-2190 of 21803 for platelets

  1. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Platelet (PLT) ≥ 75,000/uL; Serum total bilirubin within normal range (or ≤ 1.5 x upper limit of normal [ULN] if liver metastases are present; or total ...

  2. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

    * Platelets < 100 × 109/L * Leucocytes < 3 × 109/L * Neutrophils < 1.5 × 109/L * Multiorgan transplant recipient (except for previous multiple kidney ...

  3. Funding - Division of Emergency Medicine Research

    Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (U01NS062835-06), National Institute of Neurological Disorders and Stroke, 05 ...

  4. Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform - Mayo Clinic

    Platelet count ≥100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤ 3 x ULN (≤ 5 x ULN for ...

  5. Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma - Mayo Clinic

    * Platelet count \>= 100,000/mm\^3 or \>= 75,000/mm\^3 if due to lymphomatous marrow or spleen involvement (obtained =\< 30 days prior to registration) * ...

  6. Accelerated vs Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours - Mayo Clinic

    Adequate bone marrow function with ANC ≥1.0 x 10^9/L, Platelet count ≥100 x 10^9/L. Adequate liver function where bilirubin must be ≤ 1.5 x ULN, except ...

  7. A Study Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma - Mayo Clinic

    Platelet Count ≥ 100,000/mm3;; Hemoglobin ≥ 10 mg/dL* ;; Total Bilirubin ≤ 1.5 x upper limit of normal (ULN)** ;; AST/ALT ≤ 3.0 x ULN;; Creatinine < 1.5 x ...

  8. A Study of MTI-301 in Patients with Advanced Malignancy - Mayo Clinic

    Participation eligibility · Hemoglobin ≥ 9.0 g/dL · Absolute neutrophil count (ANC) ≥ 1500/mm3 · Platelet count ≥ 100,000/mm3 · Total bilirubin ≤ 1.5 x ULN.

  9. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    Platelet count 100,000/mm3; Hemoglobin ≥11.0 g/dL; Aspartate transaminase (AST) 3 x ULN; Creatinine 1.5 X ULN; Total bilirubin ≤1.5 x upper limit of normal ...

  10. Spine Care - Doctors - Mayo Clinic

    Min Yoo, M.D.. Physiatrist. Phoenix, AZ. Areas of focus: Rehabilitation therapy, Ultrasound-guided musculoskeletal injection, Platelet rich plasma injection, ...